 |  Kre-Alkalyn, Pure Encapsulations
( Manufacturer's Sku #: KRE1 )
Size: 180 VegiCaps
Suggested Retail Price: $36.20
Price: $36.20
| | Free Shipping is included on the price. | |
Patented, alkaline creatine; No loading phase required
Kre-Alkalyn is a patented, next-generation, alkaline creatine, also referred to as “The Metabolic Acid Buffer™.”
Its key features include:- Alkaline pH creatine, providing enhanced support for lactic acid and metabolic acid buffering*
- Enables a high concentration of cellular creatine to be absorbed
- Lower effective dose
- Requires no loading phase
- Does not cause water retention
- May be taken daily for sustained energy
Several case study reports involving professional male football players and endurance athletes indicate that it supports energy, endurance, stamina, muscle comfort and body composition. In a random, double blind clinical trial, Kre-Alkalyn® pH balanced creatine supported muscular performance in Olympic-level weight lifting athletes. Kre-Alkalyn® is a newly developed, alkaline buffered creatine that helps to enhance energy and strength and lessen muscle soreness due to lactic acid.
†Kre-Alkalyn® is a registered trademark of Bioceutical Research and Development Laboratory (BR&D). Kre-Alkalyn® is a US-patented product (US Patent 6,399,661).
Suggested Use
3 capsules a half hour before a workout on training days. On non-training days, take 1–3 capsules in the morning.
| Supplement Facts (Kre-Alkalyn) | |
Container Size 180 VegiCaps | | Serving Size 3 Vegi Cap |  | | | Amount Per 3 Vegi Cap | Content | %DV | | | | | | Kre-Alkalyn® (pH balanced creatine) | 1500 mg | | | | | % Daily Values (DV) are based on a 2,000 calorie diet.
* Daily Value (DV) not established. |
|
|
|
- The statements provided are for information use only and is not intended to substitute advice from your physician or health care provider. Always follow the manufacturer's recommended dosage or suggested use. If you have any special medical condition including pregnancy or nursing, consult your physician.
|
|
|
